- Home
- TEVA vs BR Comparison
TEVA vs BR Comparison
Compare TEVA & BR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEVA
- BR
- Stock Information
- Founded
- TEVA 1901
- BR 1962
- Country
- TEVA Israel
- BR United States
- Employees
- TEVA N/A
- BR N/A
- Industry
- TEVA Biotechnology: Pharmaceutical Preparations
- BR Business Services
- Sector
- TEVA Health Care
- BR Consumer Discretionary
- Exchange
- TEVA Nasdaq
- BR Nasdaq
- Market Cap
- TEVA 23.7B
- BR 28.1B
- IPO Year
- TEVA N/A
- BR 2007
- Fundamental
- Price
- TEVA $16.75
- BR $235.23
- Analyst Decision
- TEVA Strong Buy
- BR Hold
- Analyst Count
- TEVA 6
- BR 7
- Target Price
- TEVA $24.17
- BR $239.17
- AVG Volume (30 Days)
- TEVA 15.5M
- BR 430.2K
- Earning Date
- TEVA 01-29-2025
- BR 01-31-2025
- Dividend Yield
- TEVA N/A
- BR 1.50%
- EPS Growth
- TEVA N/A
- BR 11.55
- EPS
- TEVA N/A
- BR 6.40
- Revenue
- TEVA $16,544,000,000.00
- BR $6,682,900,000.00
- Revenue This Year
- TEVA $5.31
- BR $9.85
- Revenue Next Year
- TEVA $1.18
- BR $5.19
- P/E Ratio
- TEVA N/A
- BR $36.77
- Revenue Growth
- TEVA 4.40
- BR 5.73
- 52 Week Low
- TEVA $12.51
- BR $188.30
- 52 Week High
- TEVA $22.80
- BR $244.47
- Technical
- Relative Strength Index (RSI)
- TEVA 35.64
- BR 45.28
- Support Level
- TEVA $16.08
- BR $230.87
- Resistance Level
- TEVA $17.63
- BR $242.00
- Average True Range (ATR)
- TEVA 0.54
- BR 3.89
- MACD
- TEVA 0.01
- BR -0.94
- Stochastic Oscillator
- TEVA 39.82
- BR 32.06
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About BR Broadridge Financial Solutions Inc.
Broadridge Financial Solutions, which was spun off from Automatic Data Processing in 2007, is a leading provider of investor communications and technology-driven solutions to banks, broker/dealers, traditional and alternative-asset managers, wealth managers, and corporate issuers. Broadridge is composed of two segments: investor communication solutions and global technology and operations.